Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00989937 · ClinicalTrials.gov registry record · NA
Oxytocin Add-on Study for Stable Anxiety Patients
A NA study, sponsored by University of California, San Diego.
- Terminated
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT00989937 is a NA study that was terminated before completion, run by University of California, San Diego. The registered enrollment target is 17 participants.
The verdict
NCT00989937, a NA study, was terminated before completion, sponsored by University of California, San Diego.
- TERMINATED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The objective of the study is to compare the efficacy of intranasal oxytocin versus intranasal placebo to improve anxiety symptoms in patients with a variety of anxiety disorders.
Interventions
- DRUG Placebo
- DRUG Oxytocin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2009-02 |
| Est. Completion | 2011-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00989937
The ClinicalTrials.gov registry entry for NCT00989937 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00989937 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00989937 about?
NCT00989937 is a clinical study titled "Oxytocin Add-on Study for Stable Anxiety Patients". The objective of the study is to compare the efficacy of intranasal oxytocin versus intranasal placebo to improve anxiety symptoms in patients with a variety of anxiety disorders.
What is the current status of trial NCT00989937?
This trial is currently terminated. It is a NA study. The enrollment target is 17 participants. The study started on 2009-02. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00989937?
The interventions under investigation include: Placebo (DRUG), Oxytocin (DRUG).
Who is sponsoring clinical trial NCT00989937?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.